Operating Income: The income after operating expenses.
Anavex Life Sciences Corp. (AVXL) had Operating Income of $-51.41M for the most recently reported fiscal year, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-46.38M |
|
-- |
|
-- |
|
$51.41M |
|
|
Operating Income |
$-51.41M |
$5.03M |
|
$-46.38M |
|
$-46.38M |
|
$-46.38M |
|
$-46.38M |
|
$-46.38M |
|
$-46.38M |
|
$-51.41M |
|
$-51.41M |
|
85.29M |
|
85.29M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$103.81M |
|
-- |
|
-- |
|
$103.81M |
|
$8.95M |
|
-- |
|
-- |
|
$8.95M |
|
$94.87M |
|
$94.87M |
|
$94.87M |
|
86.67M |
|
| Cash Flow Statement Financials | |
$-39.04M |
|
-- |
|
$9.43M |
|
$132.19M |
|
$102.58M |
|
$-29.61M |
|
$11.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-48.89% |
|
-48.89% |
|
-44.67% |
|
-48.89% |
|
$1.09 |
|
$-0.46 |
|
$-0.46 |
|